AUTHOR INDEX

November 1, 1988

Abrahams, P. J., 6054Amano, T., 6115Andersen, J., 6227Anderson, S. L., 6006Anti-unis. A., 6201Arancia, G., 6193Arle«,C. F., 6090Ascari, E., 6238Astesano, A., 6201

Baas, F., 5927Baker, M. A., 5947Bentley, K. S., 5969, 5977Berends, F., 6058Bergeron, C., 6132Biedler, J. L., 5927Bird, R. P., 6183, 6187Bizzi, A., 6222Black, A., 5989Blask, D. E., 6121Blumberg, P. M., 5984Bobbin, L., 6081Boissard, C., 6201Borch, R. F., 6017Borst, P., 5927Bostrom, B., 5933Brady, J. F., 5937Braunschweiger, P. G., 6011Breitman, M. L., 6109Broughton, B. C., 6090Brown, J. M., 5947Browne, C. P., 6081Brugnatelli, S., 6238Butler, L. D., 6081

Case, D. C., Jr., 6246Cheng, Y-c., 5956Christensen, L., 6227Clemmensen, I., 6227Codegoni, A. M., 6222Coffey, D. S., 6050Colburn, N. H., 6076Conney, A. H., 5941Corvalan, J. R. F., 6211

Danova, M., 6238deFazio, A., 6037de Jong, F. H., 6063DeLong, D., 6081DeNeve W. J., 6002Dijt, F. J., 6058Dillman, R. O., 6097Dormer, P., 6238

Ervin, T. J., 6246Everett, C. K., 6002

Fatteh, M. V., 5969, 5977Fellenz, M. P., 5917Fellinger, E. J., 6127Ferenczy, A., 6132Ferguson, P. J., 5956Fichtinger-Schepman, A. M. J.,

6058Fisher, M. H., 5956Formisano, G., 6193Freeman, J., 5989Fritsch, A., 6127Fujioka, S., 6137Furmanski, P., 6011

Gadski, R., 6081Gali, P., 6201Garns, R., 6246Gemma, A., 6025Gerweck, L. E., 5917Gezer, S., 5989

Girino, M., 6238Gollapudi, B. B., 5953Gotoh, M., 6025Greco, C., 6193Green, S., 6090Grisham, J. W., 5969, 5977

Haffen, K., 6173Hamilton, G., 6127Hamilton, T. C., 5927Harcourt, S. A., 6090Hawkes, M. M., 6161, 6166Hay, F. G., 6161,6166Hayward, I. P., 6166Heim, S., 5911Hejblum, G., 6201Hellermann, G. R., 6006Henderson. G. B., 5995Herberman, R. B., 6069Keuch, L, 6217Hilgers, J., 6161,6166Hill, S. M., 6121Hiño,A., 6154Hinson, N. A., 6211Hirst, V. K., 5947Hitomi, S., 6154Hogenkamp, H. P. C., 5933Homma, S., 6044Huang, M-T., 5941Hui Bon Hoa, D., 6201

Ikeda, S., 6154Imren, S., 5989Inaba, S., 6029losi, F., 6193Isaacs, J. T., 6050Ishizaki, H., 5937Ito, M., 6154Ivhed, I., 6103

Joenje, H., 5927Johnson, C. S., 6011Johnson, D. E., 6097

Ramano, Y., 5984Kannagi, R., 6154Kedinger, M., 6173Kerbel, R. S., 6109Kharbanda, S. M., 5965King, M. D., 6090Kolset, S. O., 6103Kosano, H., 6033Koutcher, J. A., 5917Koziol, J. A., 6097Kubota, K., 6234Kufe, D. W., 5965Kumar, N., 6011Kurabayashi, H., 6234Kurata, M., 6154Kvâle,G., 6217

Lagarde, A., 6109Laguzza, B.C., 6211Lamberts, S. W. J., 6063Landoni, F., 6222Langdon, S. P., 6161,6166Laudonio, N., 6193Lawrie, S. S., 6161,6166Layman, N. K., 6081Lee, L. W., 5969, 5977Lehmann, A. R., 6090Léonard,R. C. F., 6161, 6166Li, D., 5937Li, D-h., 5956Lin, C-VV.,6115Linscombe, V. A., 5953Lunn, R. M., 6006

Maciak, R. S., 6211MacKie, R. M., 6090Malorni, W., 6193Mandahl, N., 5911Manetta, J., 6081Mangioni, C., 6222Marangolo, M., 6193Marder, P., 6081,6211Marcili, G., 6222Marie, J-C., 6201Marsoni, S., 6222Mathis, G. A., 6145Mazzini, G., 6238McDonald, A., 6166McLellan, E. A., 6183, 6187McNally, N. J., 6238Meyers, M. B., 5927Mirkin, B. L., 5933Milani, K., 6137Mitelman, F., 5911Miyaké,M., 6154Miyaké,N., 6154Miyawaki, S., 6234Mizuguchi, M., 6137Montine, T. J., 6017Murakami, H., 6234Musgrove, E. A., 6037

Nakahara, K., 6137Nakajima, T., 6025Nakamura, Y., 6076Naruse, T., 6234Natarajan, A. T., 6090Ngwenya, B. Z., 6044Nielsen, M., 6227Niitani, H., 6025Nilsson, K., 6103Nogiwa, E., 6234Noguchi, M., 6025

Oda, H., 6137Oldham, F. B., 6246Omine, M., 6234Ord, V., 60110vervatn, A., 6103Ozols, R. F., 5927

Partin, A. W., 6050Paul, S. D., 6246Pettit, G. R., 5984Pitot, H. C., 6249Prout, G. R., Jr., 6115

Raza, A., 5989Reedijk, J., 6058Riccardi, A., 6238Richardson, N. K., 6006Riedl, P., 6081Rochette-Egly, C., 6173Rosselin, G., 6201Rubin, B. Y., 6006Rutledge, A. R., 6115

Sato, K., 6249Sato, S., 6234Sawamura, M., 6234Schol, D. J., 6161,6166Schouten, R., 6054Schratter, I., 6127Sekiya, T., 6025Selker, R. G., 6069Shawler, D. L., 6097Sherman, M. L., 5965Shimosato, Y., 6025Shimoyama, M., 6029Shinonome, S., 6234

Shiraishi, M., 6025Shirakura, T., 6234Shulok, J. R., 6115Shyamala, G., 6132Sinha, A. K., 5953Sirica, A. E., 6145Smart, R. C., 5941Smith, B. M., 6076Smith, G. J., 5969, 5977Smith, L. J., 6006Smith, W., 6211Smyth, J. F., 6161,6166Sonneborn, H. L., 6246Spina, A. M., 6222Spriggs, D. R., 5965Starling, J. J., 6211St. Claire, D. A., Jr., 6044Stefanini, M., 6090Steingrimsdottir, H., 6090Stephenson, J., 5956Stephenson, J. B. P., 6090Strnad, J., 6081Suminski, J. E., 6002

Takanashi, R., 6137Takatani, O., 6033Taki, T., 6154Tamura, J., 6234Tanaka, F., 6137Tang, J., 6081Tange, T., 6137Tattersall, M. H. N., 6037Taylor, A. M. R., 6090Thomas, M., 6109Toft, D.O., 6132Tolmie, J. L., 6090Torri, W., 6222Treiger, B., 6050Trial, J., 5922Tsuchiya, J., 6234Tsuji, J. M., 5995

Ucci, G., 6238Uitterlinden, P., 6063Urano, Y., 6137Ursin, G., 6217

Valeriote, F. A., 6002Van der Bliek, A. M., 5927van der Eb, A. J., 6054van der Kleij, A. A. M., 6054Van der Velde-Koerts, T., 5927Vaupel, P. W., 5917

Waghorne, C., 6109Walls, S. A., 6145Wang, Y. L., 6069Warren, B. S., 5984Watanabe, P. G., 5953Wendel, E. J., 6076Whiteside, T. L., 6069Wilson, G., 6238Winterstein, D., 6076Wong, C-Q., 5941

Yamaguchi, K., 6137Yamamoto, N., 6044Yamasaki, I., 6137Yang, C. S., 5937Yasin, Z., 5989Yasuda, H., 6137Yatomi, Y., 6137

Zeman, E. M., 5947Zempel, J. A., 5953Zhou, B-s., 5956Zupi, G., 6193

6254

U.S. Postal Servie«

STATEMENT OF OWNERSHIP, MANAGEMENT AND CIRCULATIONRequiredby 39 U.S.C. 3685)

1A. Title of Publication

Cancer Research3. Frequency of Issue

1B. PUBLICATION NO.

00085472

2. Date of Filing

10-1-88

Semimonthly

3A. No. of Issues PublishedAnnually

24

3B. Annual Subscription Price

$260

4. Complete Mailing Address of Known Office of Publication (Street. City. County, Stale and ZIP+4 Code) (Not printers)

530 Walnut Street, 10th FloorPhiladelphia, PA 19106

5. Complete Mailing Address of the Headquarters of General Business Offices of the Publisher (Noiprinter)

same as above

6. Full Names and Complete Mailing Address of Publisher, Editor, and Managing Editor (77m item MUST NOT be blank)Publisher (Name and Complete Mailing Address)

American Association for Cancer Research530 Walnut Street, 10th Floor, Philadelphia, PA 19106

Editor (Nameand CompleteMailingAddress)Dr. Peter N. Magee, American Association for Cancer Research,530 Walnut Street, 10th Floor, Philadelphia, PA 19106

Managing Editor (Name and Complete Mailing Address)

Ms. Margaret Foti, American Association for Cancer Research,530 Walnut Street, 10th Floor, Philadelphia, PA 19106

7. Owner (If owned by a corporation, its name and address must be slated and also immediately thereunder the names and addresses of stockholders owning or holding1 percent or more of total amount of stock. If not owned by a corporation, the names and addresses of the individual owners must be given, if owned by a partnershipor other unincorporated firm, its name and address, as welt as thai of each individual must be given. If the publication is published by a nonprofit organization, itsname and address must be slated.) (Item must be completed.)

Full Nam« Complete Mailing Address

8. Known Bondholders, Mortgagees, and Other Security Holders Owning or Holding 1 Percent or More of Total Amount of Bonds. Mortgages or OtherSecurities (If there are none, so state)

Full Name Complet«Mailing Address

9. For Completion by Nonprofit Organizations Authorized To Mail at Special Rates (DMM Section 423.12 only)The purpose, function, and nonprofit status of this organization and the exempt status for Federal income tax purposes (Checkone)

ID1Has Not Changed DuringJPreceding 12 Months

(2)|—IHas Changed DuringI—IPreceding 12 Months

(If changed, publisher must submit explanation ofchange with this statement.)

10. Extent and Nature of Circulation(Seeinstructionson reverseside)

Average No. Copies Each Issue DuringPreceding 12 Months

Actual No. Copies of Single IssuePublished Nearest to Filing Date

A. Total No. Copies (NetPress Run)7225 7307

B. Paid and/or Requested Circulation * SEE BELOW1. Sales through dealers and carriers, street vendors and counter sales

220 24n2. MailSubscription

(Paidand/orrequested) 6146 ft ,11 9C. Total Paid and/or Requested Circulation

(Sumor WBl and 10B2) 6366D. Free Distribution by Mail, Carrier or Other Means

Samples. Complimentary, and Other Free Copies78

E. Total Distribution «umof C and D)6444

F. Copies Not Distributed1. Office use, left over, unaccounted, spoiled after printing

781

2. Return from News AgentsNONE -NONE-

G. TOTAL(Sumof E, FI and 2—shouldequal netpress run shownin A)

11.I certify that the statements made byme above are correct and complete

Signature and Title of Editor, Publisher. Business Manager, or Owner

t ¿PS Form 3526, Dec. 1987 (Seeinstfuationson reverse) *Paid Subs. mailed via Canada Post

6255

AMERICAN ASSOCIATION FOR CANCER RESEARCH

INFORMATION ON APPLICATION FOR ACTIVEAND CORRESPONDING MEMBERSHIP

BENEFITS OF MEMBERSHIP

The American Association for Cancer Research (AACR) is ascientific society consisting of laboratory and clinical cancerresearchers. It was founded in 1907 "to bring together active

investigators of the cancer problem for presentation and discussion of new or significant observations; and to foster research incancer and other phenomena of growth." Members of the AACR

enjoy the following benefits:

1. a subscription to the journal Cancer Research at thereduced member rate;

2. the privilege of sponsoring an abstract for presentation atthe AACR annual meeting;

3. an advance copy of the Program and Proceedings pertaining to each annual meeting;

4. a reduced registration rate at the annual meeting;5. early notification of events in the AACR's new series of

small scientific meetings;6. subscriptions to any future AACR journals at reduced

member rates;7. preferred access to the AACR Employment Register;8. the receipt of AACR newsletters, meeting announcements,

and an up-to-date membership directory.

QUALIFICATIONS FOR MEMBERSHIP

Active membership in the AACR is open to investigators wholive in the Americas, and who have conducted two years ofmeritorious research that has resulted in publications relevant tocancer. If a candidate is working in a research area not directlyrelated to the cancer field but has conducted research of exceptional scientific merit, he or she may also qualify for membership.

Corresponding membership is open to qualified persons whoare not residents of the Americas. The requirements for corresponding membership are the same as those for active membership. Visiting scientists from outside the Americas who intendto return to their countries of origin soon after submitting theirapplications should apply for corresponding membership. Allother individuals should apply for active membership and transferto corresponding status at a later date if they should leave theAmericas.

PROCEDURES FOR APPLICATION

There are two deadlines for receipt of a membership application: August 1 and December 1 of each year. The MembershipCommittee will review all complete applications for active membership that have been received by these deadlines and willsubmit recommendations on each candidate to the Board ofDirectors, which formally elects all members. The same procedure is followed by the Special Memberships Committee, whichreceives applications for corresponding membership. Applicantswho meet the August 1 deadline will be notified of the Board's

decision in November, and, if elected, will be eligible to sponsoran abstract for the annual meeting of the AACR to be held thefollowing Spring. Applicants meeting the December 1 deadlinewill be notified about their election in March.

A complete application consists of the following material:

1. 6 copies of the form on the opposite side of this page,with all requested information provided.

2. 5 copies of the candidate's most current curriculum vitae

and bibliography.3. 5 copies of a letter of recommendation from a nominator

who is an active, emeritus, or honorary member of theAACR (at least one copy must be a signed, original letter).This letter should describe the candidate's achievements

in laboratory research, clinical investigations, or epidemi-ological research, and it should affirm that this researchadheres to accepted ethical standards.—OR—The nominator may supply the responses requested at the bottomof the application form in the section entitled "STATEMENT OF SUPPORT" (at least one copy of the form must

be the signed original).4. 5 copies of a letter of recommendation as described in

Item 3. above from a seconder who is an active, emeritus,or honorary member of the AACR (at least one copy mustbe a signed, original letter).—OR—The seconder maysupply the responses requested at the bottom of theapplication form in the section entitled "STATEMENT OFSUPPORT" (at least one copy of the form must be the

signed original).5. 5 reprints of each of two publications on which the candi

date appears as author.All material should be collated into five complete sets with the

original application form as a covering document and sent to theaddress given below. Questions regarding procedures for membership application may also be directed to the following address:

American Association for Cancer Research530 Walnut Street

Tenth FloorPhiladelphia, PA 19106

215/440-9300

RESPONSIBILITIES OF MEMBERSHIP

Candidates should be aware of the following responsibilitiesof membership in the AACR. Active members must pay annualdues, a major portion of which is designated for a subscriptionto the AACR's official publication outlet, Cancer Research. Newly

elected members of the AACR who have already purchasedsubscriptions to Cancer Research at the higher, nonmember ratewill receive reimbursement of the unused portion of that subscription once their first year's membership dues are paid in full.

All corresponding members elected after May 23, 1985, arerequired to pay an annual assessment in lieu of dues. Thisassessment, which is equivalent to that portion of the regulardues that pertains to support of activities other than the journalCancer Research, is imposed to defray the cost of sending AACRpublications to members outside the Americas. Correspondingmembers may, if they wish, subscribe to Cancer Research atthe reduced member rate.

Successful candidates will be expected to begin paying duesto the AACR in the year following receipt of their applications;e.g., successful applicants who meet either the August 1, orDecember 1,1988 deadlines will begin to pay dues in 1989.

Margaret FotiExecutive Director

AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC.530 Walnut Street

Tenth FloorPhiladelphia, PA 19106

APPLICATION FOR MEMBERSHIP

CATEGORY OF MEMBERSHIP:

NAME OF CANDIDATE:

D Active D Corresponding

DATE OF BIRTH:

PRESENT POSITION/TITLE: _INSTITUTIONAL AFFILIATION:INSTITUTIONAL ADDRESS: _

(City)TELEPHONE NUMBER:

(State/Province) (Country)SOCIAL SECURITY NUMBER:

(Postal Code)

PRIMARY FIELD OF RESEARCH (Please check only one):Biochemistry and Biophysics BiostatisticsCellular Biology and Genetics Clinical InvestigationsEpidemiology ImmunologyPreclinical Pharmacology and Experimental Therapeutics

Virology Other:

CarcinogenesisEndocrinology

. Molecular Biology and Genetics

(Please specify)

ACADEMIC DEGREES (Including where and when granted)

EXPERIENCE SINCE HIGHEST DEGREE WAS GRANTED (Please list most recent first)

PUBLICATIONS (Reprints of two articles on which the candidate appears as an author must accompany this application. For thesetwo articles list the authors, title, journal, volume, inclusive pages, and year. Do not submit abstracts.)

CANDIDATE NOMINATED BY:(Please type or print)

CANDIDATE SECONDED BY:(Please type or print)

STATEMENT OF SUPPORT (in place of letters of recommendation)Instead of submitting letters of recommendation, either the nominator or the seconder or both may complete the following section:

How long has the candidate worked in the field of cancerresearch? yearsWill the candidate make a long-term contribution to cancerresearch? Yes NoDoes the candidate's research adhere to accepted ethical stand

ards? Yes No

I therefore recommend this candidate for membership in theAmerican Association for Cancer Research.

How long has the candidate worked in the field of cancerresearch? yearsWill the candidate make a long-term contribution to cancerresearch? Yes NoDoes the candidate's research adhere to accepted ethical stand

ards? Yes No

I therefore recommend this candidate for membership in theAmerican Association for Cancer Research.

Signature of nominator Date Signature of seconder

See Guidelines for Application on the reverse side of this form for further instructions.

Date

(This form may be reproduced.) 1118

AMERICAN ASSOCIATION FOR CANCER RESEARCH

GUIDELINES FOR APPLICATION FOR ASSOCIATE MEMBERSHIP

QUALIFICATIONS FOR MEMBERSHIP

Associate membership is open to graduate students, medicalstudents, postdoctoral fellows, and physicians in training who live inthe Americas and who are following a course of study or who areworking in a research program relevant to cancer.

BENEFITS OF MEMBERSHIP

The American Association for Cancer Research (AACR), a scientific society consisting of laboratory and clinical cancer researchers, was founded in 1907 "to bring together active investigators of

the cancer problem for presentation and discussion of new or significant observations; and to foster research in cancer and otherphenomena of growth." Associate members of the AACR enjoy the

following benefits:

1. the privilege of sponsoring an abstract for presentation at theAACR annual meeting provided that (a) the associate member is the presenter of the abstract and (b) an active memberin good standing of the AACR also signs the abstract in support of the work (In this instance, the active member who co-signs the abstract does not lose his or her own sponsorshipprivilege.);

2. an advance copy of the Program and (if one has been purchased by the associate member) the Proceedings of theAmerican Association for Cancer Research which containsabstracts of all papers being presented at each annual meeting;

3. the privilege of registering for the annual meeting at the lowstudent rate (This rate is otherwise available only to predoc-toral students.);

4. preferred access to the AACR Employment Register;5. an optional subscription to the journal Cancer Research at

the reduced member rate;6. subscriptions to any future AACR journals at reduced mem

ber rates;7. early notification of events in the AACR's new series of small

scientific meetings on timely scientific topics;8. the receipt of AACR newsletters, meeting announcements,

and an up-to-date membership directory; and9. the facilitation of informal scientific exchange with leading

researchers in the cancer field.

PROCEDURES FOR APPLICATION

Persons wishing to apply for associate membership must use theofficial application form on the reverse side of these instructions.Each candidate for associate membership must be nominated byan active member in good standing of the AACR. Three completedcopies of the form should be submitted; at least one of these copiesmust carry the original signatures of both the candidate and theactive member nominator. The application form may be submitted

to the Association Office at any time. After review of applications forassociate membership, the Executive Director will notify candidates of their election or deferral within one month of the receipt ofthe application form. A check in the amount of $20, which represents one year's dues payment, must accompany the application.

This fee will be refunded to any candidate deemed to be ineligiblefor associate membership. Checks should be in U.S. currency,made payable to AACR, Inc., and drawn on a U.S. bank. Send thethree copies of the application form and the $20 dues payment to:

American Association for Cancer Research530 Walnut Street - 10th Floor

Philadelphia, PA 19106215/440-9300

RESPONSIBILITIES OF MEMBERSHIP

Associate members must pay annual dues in an amount to bedetermined by the AACR Board of Directors. Dues for 1988 and1989 have been set at $20 per year. If an application is submitted byAugust 31, the accompanying dues payment will be credited to thecurrent year. Candidates submitting applications between September 1 and December 31 may indicate whether they wish their duespayments credited to the current or forthcoming year. Candidatesshould be aware, however, that associate members may sponsoran abstract for the annual meeting only if their dues for the currentyear are paid. For example, an associate member submitting anabstract in December 1988 for the forthcoming annual meetingmust have paid dues for 1988. Any newly elected associate members of AACR who have already purchased subscriptions to CancerResearch at the higher, nonmember rate will receive a refund forthe unused portion of that subscription upon receipt of their payment for a member's subscription.

Each Fall the AACR will send to current associate members aninvoice for dues for the forthcoming year. Payment of this invoicemust be accompanied by a statement signed by the associatemember's registrar, dean, or department head, verifying the member's current academic status. The Association's By-Laws state

that dues are payable for each year in advance on or before January 1 of that year. An individual may be an associate member for amaximum of five years. Each year in which an individual pays dueswill count as one full year of associate membership. Thus, an associate member who pays dues for 1988 may retain associate membership until December 31, 1992. The Board of Directors mayterminate the membership of any associate member whose duesare in arrears for two years.

Margaret Foti,Executive Director

AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC.530 Walnut Street - 10th Floor

Philadelphia, PA 19106

APPLICATION FOR ASSOCIATE MEMBERSHIP

NAME OF CANDIDATE: DATE OF BIFTTH:

INSTITUTIONAL AFFILIATION:INSTITUTIONAL ADDRESS:

(City) (State/Province) (Postal Code) (Country)TELEPHONE NUMBER: SOCIAL SECURITY NUMBER:

PRESENT ACADEMIC STATUSATITLE:(Please check only one):Graduate Student Medical StudentPhysician in Training Postdoctoral Fellow

PRIMARY FIELD OF RESEARCH (Please check only one):Biochemistry and Biophysics Biostatistics CarcinogenesisCellular Biology and Genetics Clinical Investigations EndocrinologyEpidemiology Immunology Molecular Biology and GeneticsPreclinical Pharmacology and Experimental TherapeuticsVirology Other:

(Please specify)ACADEMIC DEGREES (Please indicate degree(s) acquired to date along with the name of the academic institution and date of receipt.Provide information on degree currently being sought and the anticipated date of completion of this degree program.)

RELEVANT RESEARCH EXPERIENCE NOT RELATED TO COURSE WORK (Please list most recent first.)

PUBLICATIONS (List the authors, title, journal, volume, inclusive pages, and year of any article in a peer-reviewed journal on which thecandidate appears as an author. Do not list abstracts. Continue on a separate sheet, if necessary.)

CANDIDATE NOMINATED BY:(Please type or print name of AACR active member in good standing.)

SIGNATURESI hereby apply for associate membership in the American Association for Cancer Research. I have read the instructions on the reverseside of this form, and I understand the privileges and responsibilities of this class of membership. I certify that the statements on thisapplication are true.

Signature of Candidate: Date:

I recommend this candidate for associate membership in the American Association for Cancer Research. To the best of my knowledge,the candidate is qualified for this class of membership, and the statements on this application are true.

Signature of Nominator: Date:

Submit three copies of this form. At least one copy must contain the original signatures of the candidate and the nominator. Enclose acheck for $20 in U.S. funds made payable to AACR, Inc. and drawn on a U.S. bank. Check one of the following boxes only if this form isbeing submitted between September 1 and December 31:

The enclosed dues payment should be applied to the

D current D forthcoming calendar year.

(NOTE: If dues are applied to the forthcoming year, membership will take effect on January 1.) See Guidelines for Application on thereverse side of this form for further instructions.

(This form may be reproduced.) 1118

CASSETTE ORDER FORM

79th ANNUALMEETING OF THE

AMERICAN ASSOCIATIONFOR CANCER RESEARCH

May 25-28,1988

24th ANNUALMEETING OF THE

AMERICAN SOCIETY OFCLINICAL ONCOLOGY

May 22-24,1988

J964

EACH CASSETTE IS $11 50PROGRAMS MAY CONSIST OF ONE TO THREE CASSETTES

AMERICAN ASSOCIATION FORCANCER RESEARCH

O CAN801 Joint AACR/ASCO Symposium: Drug Resistance$23.00 from the Molecular Level to Clinical Management

(Twocassettes)

D CAN802 Twelfth Richard and Hinda Rosenthal Foundation$11.50 Award Lecture: Cancer Families: Human Models of

Susceptibility to Neoplasia [Frederick P l ,|(Onecassette)

D CAN803 Scientific and Public Education Symposium: The$23.00 Status of Cancer Treatment, 1988 (Two cassettes)

D CAN804 Clinical Investigations III: Clinical Investigations$23.00 (Two cassettes)

D CAN805 Minisymposium Immunology II: Immunopotentiation$23 00 by Chemotherapeutic Agents (Two cassettes)

D CAN806 Minisymposium Special Organ Site I: Breast$34.50 (Threecassettes)

O CAN807 Epidemiology II: Cancer Epidemiology II$23.00 (Two cassettes)

D CAN808 Experimental Therapeutics II: Platinum$23.00 Compounds I (Two cassettes)

D CAN809 Clinical Investigations IV: Leukemia and Lymphoma$23 00 (Two cassettes)

D CAN810 Minisymposium Preclinical Pharmacology II:$23.00 Biochemical Modulation I (Two cassettes)

D CAN811 Seventh Bruce F. Cain Memorial Award Lecture:$11 50 Oxazaphosphorine Cytostatics: Past —Present —

Future (Norbert Brockl (Onecassette)

D CAN812 Symposium II: Approaches to the Prevention of$23 00 Cancer (Two cassettes)

a CAN813 Seventh C. P. Rhoads Memorial Award Lecture:$11 50 Molecular Genetics of Familial Human Cancer

(Webster K Caveneel (Onecassette)

D CAN814 Twenty-Eighth G.H.A. Clowes Memorial Award$11.50 Lecture: Critical Factors in the Biology of Human

Cancer Metastasis (IsaiahJ Ftdlerl (Onecassette)

a CAN815 Carcinogenesis VII: Oxygen Radicals in Cancer$23 00 Etiology (Two cassettes)

O CAN816 Biology V: Differentiation II$23.00 (Two cassettes)

n CAN817 Molecular Biology/Virology V: Regulation of Gene$23 00 Expression II (Two cassettes)

D CAN818 Biochemistry Il-Phospholipids: Structure and

$23.00 Function (Two cassettes)

D CAN819 Clinical Investigations X: Bone Marrow$23.00 Transplantation (Two cassettes)

a CAN820 Experimental Therapeutics VII: Antifolates I$23.00 (Two cassettes)

D CAN821 Immunology V: Monoclonal Antibodies I$23.00 (Two cassettes)

D CAN822 Special Organ Site II: Prostate$23.00 (Two cassettes)

a CAN823 Presidential Address: Immunomodulation by$11.50 Anticancer Agents (Enrico Mihichl (Onecassette)

D CAN825 Annual Business Meeting (AACR)$23.00 (Twocassettes)

O CAN826 Symposium III: New Approaches to the Discovery of$23.00 Anticancer Agents (Two cassettes)

D CAN82? Symposium IV: Growth Factors, Oncogenes, and the$23 00 Control of Proliferation (Two cassettes)

D CAN828 Symposium V: Tumor Suppressor Genes-

$23 00 Mechanistic Aspects (Two cassettes)

D CAN829 Minisymposium Biology VIII: Signal Transduction$23.00 and Protein Kinase II (Two cassettes)

D CAN830 Special Organ Site III: Lung•$34.50 (Threecassettes)

D CAN831 Carcinogenesis XIII: Metabolic Activation of$23 00 Carcinogens II: Aromatic Amines, Nitroso

Compounds (Two cassettes)

D CAN832 Endocrinology IV: Endocrinology of Breast$23 00 Cancer II (Two cassettes)

a CAN833 Immunology X: Lymphokines and Cytokines$23.00 (Two cassettes)

D CAN834 Preclinical Pharmacology VI: Biochemical$23.00 Pharmacology II (Two cassettes)

n CAN835 Preclinical Pharmacology VII: Preclinical$23 00 Pharmacology II (Two cassettes)

D CAN836 Minisymposium Experimental Therapeutics XII:$34.50 Ether Lipid Analogs and Other Membrane-Active

Chemotherapeutic Agents (Three cassettes)

D CAN837 Biochemistry IV: DNA Modification, Damage, and$34.50 Repair (Threecassettes)

D CAN838 Biology XI: Growth Factors II$34.50 (Threecassettes)

a CAN839 Minisymposium Carcinogenesis XV: Mechanisms of$34.50 Tumor Promotion (Three cassettes)

D CAN840 Minisymposium Carcinogenesis XVI: DNA Adducts$34.50 (Three cassettes)

O CAN841 Minisymposium Immunology XIII: Cytotoxic Cells$34 50 and Cell Therapy (Threecassettes)

D CAN842 Minisymposium Molecular Biology /Virology VII:$34.50 Oncogenes and Progression (Three cassettes)

a CAN843 Experimental Therapeutics XVI: Anthracyclines II$34.50 (Threecassettes)

a CAN844 Experimental Therapeutics XVII: Alkylating$34.50 Agents II (Three cassettes)

(Continued on back)

AMERICAN SOCIETYOFCLINICALONCOLOGYD

CO801 isti Problemsin Statistics for ClinicalTrials$11.50(Onecassette)D

CO802 (S2IMultidisciplinar Approachesto SoftTissue$11.50Sarcoma(Onecassette)D

CO803 (S3)Autologous Bone Marrow Transplantationfor$1150 Adult Malignancy(Onecassette)D

CO804 IS4IBiologyandManagementof Myelodysplasia$11.50 (Onecassette)D

CO805 issi TesticularCancer$11.50(Onecassette)D

CO806 issi Current Statusof Biological ResponseModifiers$1150(Onecassette)D

C0807 is/i PainManagementandSupportiveCare$11.50(Onecassette)D

CO808 IS8)Current Issuesin the BiologyandTreatmentof$1150 SmallCell LungCarcinoma(Onecassette)a

CO809 . ' HeadandNeckCancer$11.50(Onecassette)D

C0810 isioi AlOS-Medical andSocialProblems$1150(Onecassette)O

C08I1 ism TheApplication of BasicScienceTechniquesto$11.50 the PathologicDiagnosisof PoorlyDifferentiatedNeoplasms

(Onecassette)D

CO812 (SI?) The New Biology of BreastCancer$11.50(Onecassette)D

C0813 isni RecurrentColorectalCarcinoma$11.50(Onecassette)O

C0814 (sii) Epidemiologyof ChildhoodNeoplasms$11.50(Onecassette)D

CO815 isis) Pre-invasiveBreastCancer$11.50(Onecassette)D

C0816 Forum:Clinical Trials- Whats In It ForYouandYour$1150Practice? (Onecassette)D

C08I7 Adult LymphomaandMyeloma$3450(Threecassettes)D

C0818 LungCancer:Small-Cell$23.00(Twocassettes)

D C0819 ClinicalPharmacology$23.00(Twocassettes)D

CO820 SupportiveCare PsychosocialAspectsofCancer$23.00(Twocassettes)D

CO821Sarcomas$23.00(Twocassettes)O

C0822 PresidentialAddress:AgingandCancer$11.50 IB J Kennedy!(Onecassette)D

CO823 NineteenthAnnualDavidA. KarnofskyMemorial$11.50 Lecture: Virus' of CancerandImmunodeficiency(Robert

C Gallol (Onecassette)O

CO824 PlenarySession$23.00 (Twocassettes)O

CO825 BreastCancer$34.50 (Threecassettes)D

CO826 Adult LeukemiaandLymphoma$23.00 (Twocassettes)D

CO82? AIDS Epidemiology CancerPreventionandControl$23.00 (Twocassettes)DCO828 LungCancer:Non-Small-Cell$2300 (Twocassettes)D

CO829 CNSTumors/Melanoma$34.50 (Threecassettes)D

CO830 PediatrieSolidTumors$23.00(Twocassettes)D

CO831 GastrointestinalTractCancer$34.50(Threecassettes)D

CO832 GenitourinaryTract Cancer/GynecologicalTumors$34.50(Threecassettes)O

CO833 Pediatrie LeukemiaandLymphoma$23.00(Twocassettes)D

CO834 ImmunologyandCancerBiology$34.50(Threecassettes)D

CO835 HeadandNeckCancer$34.50(Threecassettes)DISCOUNTS:1-5

tapes $11.50Each12

24tapes 10%Discount2548tapes 15%Discount49ormoretapes 20%DiscountHOW

TO ORDER : 1 Check the cassettes you want °'d"T*"»'2.Fill in name and address below *ff£ 1 800225-37753.Mail your order to Teach 'em, Inc., 160 E Illinois St., Chicago, IL 6061 1 (312) 467-0424.

Amount of order

Foreign Countries Please add appropriate air mail postage

Sales tax (IL aiders only)

Billing charge (il applicable)

Shipping and Handling

Total amount of order (in U S funds)PIMM Indicai»: G Check enclosed (payable to T»»ch'cm, Inc.)

n VISA D MasterCard [J AMEX Expires

£ Name Title

3.00

I I Bill me and add $3 for billingCard No _

Organization

UJ Street Address (No P O Bones, please)-

5 City _ Slate ZIP

Telephone ( Signature

PK-6100

ABCKIT

Thenew^ü^VectastairrABCSystemfromVector.This new peroxidase-based detection system provides the highest sensitivity available.

Through improvements in the patented preformed Avidin/Biotin Complex technique, fasterstaining is now possible while still retaining the low background characteristic of the VECTA-STAIN®ABC System. In addition, substantially less primary antibody is required to achievestaining equivalent to other peroxidase-based immunohistochemical detection methods. TheVECTASTAIN* <%i& ABC is ideal for all immunohistochemical applications, for Southern,

Western and Northern blot techniques, and for enzyme immunoassays.Join the ¿íííL! Phone or write us now for further information about the newest member

of the VECTASTAIN®family. Vector Laboratories, Inc. 30 Ingold Road, Burlingame, CA 94010 (415)697-3600Vector Laboratories-U.K. 16WulfrieSquare, Bretton,PetersboroughPE3 8RF England (0733) 265530

VECTORLABORATORIES